Company
Korea United Pharm. Inc.
Korea United Pharm. Inc. has 1 drug tracked on RxWires: 1 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Semaglutide (UI112) | Phase 1 | Bioequivalence |
Latest
No recent events.
Follow Korea United Pharm. Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.